Skip to main content
. 2021 Oct 6;18(11):4079–4089. doi: 10.1021/acs.molpharmaceut.1c00480

Table 2. Formulation of the ASDs with the Weight Ratio of Each Component.

polymer-drug system polymer (% w/w) drug(s) (% w/w) drug ratioa
PVP-ATV 90 10 n/a
PVP-RTV 90 10 n/a
PVP-ATV-RTV 90 10 25:75
PVP-ATV-RTV 90 10 50:50
PVP-ATV-RTV 90 10 75:25
HPMCAS-FDN 80 20 n/a
HPMCAS-IPM 80 20 n/a
HPMCAS-FDN-IPM 80 20 25:75
HPMCAS-FDN-IPM 80 20 50:50
HPMCAS-FDN-IPM 80 20 75:25
HPMCAS-FDN-IPM 80 20 90:10
a

Only applicable for formulations containing two drugs. n/a: not applicable.